Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

Heterocyclic Compounds > Heterocyclic Compounds, Fused-Ring > Heterocyclic Compounds, 4 or More Rings > Ergolines > Cabergoline
Heterocyclic Compounds > Alkaloids > Ergot Alkaloids > Ergolines > Cabergoline

Preferred term

Cabergoline  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea

Scope note

  • An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.

History note

  • 2019 (1985)

In other languages

URI

http://www.yso.fi/onto/mesh/D000077465

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/18, last modified 7/3/18